The genomic technique, known as TALENS, is described in a report published today in the scientific journal Proceedings of the National Academy of Science. The technique is cheaper and faster than previous technologies that allow scientists to genetically modify livestock animals; the animals are used to learn more about human diseases, which in turn can help researchers develop cures. U of M scientists and their collaborators used the technique to develop a swine model of cardiovascular disease in the diabetes-prone Ossabaw miniature pig.
The TALENS technique also can be used in agriculture, the paper notes, allowing livestock breeders to encourage or discourage a particular trait.
“Our efforts continue a long tradition of responsible animal breeding and research for the betterment of mankind,” said Scott Fahrenkrug, an associate professor of animal science at the university and lead author of the PNAS paper.
Collaborators on the paper are from Texas A&M, the Roslin Institute at the University of Edinburgh and Recombinetics, a Twin Cities-based company created in 2009 to commercialize the techniques created at the University of Minnesota. The group’s work and the TALENS technique also recently were highlighted in the journal Nature.
“This work embodies the effective translation of university research into meaningful applications that support Minnesota business,” Fahrenkrug said. “We are proud to produce positive social and economic outcomes.”
Media Note: The full paper is available online at http://www.pnas.org/.
Matt Hodson, University News Service, firstname.lastname@example.org, (612) 625-0552
Becky Beyers | EurekAlert!
Cereals use chemical defenses in a multifunctional manner against different herbivores
06.12.2018 | Max-Planck-Institut für chemische Ökologie
Can rice filter water from ag fields?
05.12.2018 | American Society of Agronomy
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
17.12.2018 | Physics and Astronomy
17.12.2018 | Architecture and Construction
17.12.2018 | Life Sciences